Free Trial

Trellus Health (TRLS) Competitors

GBX 0.65 -0.05 (-7.14%)
As of 08/22/2025 10:47 AM Eastern

TRLS vs. FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COG

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

Trellus Health (LON:TRLS) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Feedback Neutral

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-12,114.55% -37.95% -22.76%
Feedback -279.16%-39.71%-22.99%

19.3% of Trellus Health shares are owned by institutional investors. Comparatively, 53.2% of Feedback shares are owned by institutional investors. 49.7% of Trellus Health shares are owned by company insiders. Comparatively, 10.8% of Feedback shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Trellus Health has higher earnings, but lower revenue than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£65.83K19.09-£7.98M-£3.45-0.19
Feedback£3.88M1.49-£10.84M-£24.74-0.54

Trellus Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.

Summary

Trellus Health beats Feedback on 7 of the 11 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.26M£340.22M£5.76B£3.22B
Dividend YieldN/A5.90%4.41%5.04%
P/E Ratio-0.19366.5131.10164.70
Price / Sales19.09218.64433.45310,110.48
Price / Cash0.7647.1437.7327.93
Price / Book0.075.119.535.91
Net Income-£7.98M-£15.55M£3.26B£5.89B
7 Day Performance-13.91%1.04%2.10%49.50%
1 Month Performance-5.25%1.53%2.81%56.36%
1 Year Performance-47.79%7.07%30.56%136.20%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.65
-7.1%
N/A-48.0%£1.26M£65.83K-0.1931Gap Down
FDBK
Feedback
N/AGBX 13
-1.9%
N/A-75.0%£5.70M£3.88M-0.5324
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-33.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,280
+1.8%
GBX 2,725
+19.5%
-2.2%£979.64M£230.77M84.24734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
3.0268 of 5 stars
GBX 157
flat
GBX 456.67
+190.9%
-50.6%£57.62M£50.72M14.75478
RENX
Renalytix
N/AGBX 5.99
+4.2%
N/A-45.3%£24.83M£9.22M-0.28102Gap Up
COG
Cambridge Cognition
N/AGBX 24.78
-0.9%
N/A-39.3%£10.37M£15.64M-6.5980

Related Companies and Tools


This page (LON:TRLS) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners